英文别名Cabergoline specified impurity [EP]; Cabergoline related compound C; (6aR,9R,10aR)-9-N-[3-(dimethylamino)propyl]-4-N-ethyl-9-N-(ethylcarbamoyl)-7-prop-2-enyl-6,6a,8,9,10,10a-hexahydroindolo[4,3-fg]quinoline-4,9-dicarboxamide; (6aR,9R,10aR)-N9-(3-(dimethylamino)propyl)-N4-ethyl-N9-(ethylcarbamoyl)-7-(prop2-enyl)-6a,7,8,9,10,10a-hexahydroindolo(4,3-fg)quinoline-4,9(6H)-dicarboxamide; Ergoline-1,8-dicarboxamide,N8-(3-(dimethylamino)propyl)-N1-ethyl-N8-((ethylamino)carbonyl)-6-(2-propenyl)-,(8beta); Cabergoline related compound C [USP]; Cabergoline EP Impurity C; (6aR,9R,10aR)-7-allyl-N9-[3-(dimethylamino)propyl]-N4-ethyl-N9-(ethylcarbamoyl)-6,6a,8,9,10,10a-hexahydroindolo[4,3-fg]quinoline-4,9-dicarboxamide; Ergoline-1,8-dicarboxamide, N8-[3-(dimethylamino)propyl]-N1-ethyl-N8-[(ethylamino)carbonyl]-6-(2-propen-1-yl)-, (8ss)-; Cabergoline impurity C; Cabergoline Impurity 6; N~8~-[3-(Dimethylamino)propyl]-N~1~-ethyl-N~8~-(ethylcarbamoyl)-6-(prop-2-en-1-yl)ergoline-1,8beta-dicarboxamide 
